№ lp_1_2_11616
File format: docx
Character count: 3598
File size: 306 KB
Year:
2019
Note:
Region / city
Subject:
Finance
Document type:
Consultation Paper
Institution:
Central Bank
Contextual description:
A consultation paper detailing the procedure for withdrawing approval of a sub-fund and the required documentation for the process.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2013
Region / City:
APEC
Theme:
Supply Chain Connectivity, Capacity Building
Document Type:
Guidelines
Organization / Institution:
APEC
Author:
APEC Secretariat
Target Audience:
APEC Member Economies
Period of Application:
2013 onwards
Approval Date:
May 2014
Date of Amendments:
Not specified
Year:
2024
Note:
Region / city
Topic:
Fund registration
Document type:
Checklist
Organization / institution:
Securities and Futures Commission (SFC)
Target audience:
Applicants for private OFC registration
Contextual description:
This is a standard checklist document for the registration of a private open-ended fund company or the establishment of a privately offered sub-fund within an open-ended fund company.
Year:
2020
Jurisdiction:
Hong Kong
Document type:
Information checklist
Regulatory authority:
Securities and Futures Commission
Division:
Investment Products Division
Legal framework:
Securities and Futures Ordinance
Related rules and codes:
Securities and Futures (Open-ended Fund Companies) Rules; Code on Open-ended Fund Companies
Effective date:
23 December 2020
Subject matter:
Registration of private open-ended fund companies and establishment of privately offered sub-funds
Applicants:
Applicants seeking registration of a private OFC or approval of privately offered sub-funds
Language of document:
English
Year:
2009
Region / City:
APEC
Theme:
Energy Efficiency, Low Carbon, Energy Resiliency
Document Type:
Guidelines
Organization / Institution:
APEC
Author:
APEC Secretariat
Target Audience:
APEC member economies
Period of Validity:
Ongoing
Approval Date:
2009
Date of Changes:
2020
Year:
2015
Region:
APEC economies
Subject:
Micro, Small and Medium Enterprises development and project funding
Document type:
Eligibility criteria and procedural guidelines
Organization:
Asia-Pacific Economic Cooperation (APEC)
Administering body:
APEC Secretariat
Related initiative:
Canada-APEC Growing Businesses Partnership
Funding mechanism:
APEC MSME Sub-Fund under the APEC Support Fund
Announced contribution:
C$2.0 million from Canada
Relevant working groups:
Small and Medium Enterprises Working Group (SMEWG); Policy Partnership on Women and the Economy (PPWE)
Maximum funding per proposal:
USD 125,000
Application components:
Concept Note and Full Project Proposal
Submission process:
APEC bi-annual project approval sessions
Target beneficiaries:
MSMEs in developing APEC economies, including women-led enterprises
Policy focus:
MSME internationalization, inclusive development, poverty reduction, gender-responsive economic participation
Year:
n/a
Region / City:
n/a
Topic:
Public health practice, ethical review
Document type:
Report
Agency/Organization:
CDC
Author:
Teresa C. Horan, BS, MPH
Target audience:
n/a
Effective period:
n/a
Approval date:
n/a
Amendment date:
n/a
Year:
2021
Region / City:
Canberra
Topic:
Alcohol withdrawal management
Document Type:
Guideline
Institution:
Canberra Health Services
Author:
Not specified
Target Audience:
Medical and nursing staff, students under supervision
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Last Revision:
Not specified
Year:
2023
Region / City:
Canberra
Subject:
Land Titles
Document Type:
Guidance Note
Organization / Institution:
Access Canberra
Author:
Not specified
Target Audience:
Legal practitioners, self-represented parties, mortgagees
Effective Period:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2020
Region / City:
United States
Subject:
Alcohol withdrawal syndrome, Benzodiazepine-sparing regimens, Inpatient outcomes
Document type:
Research Article
Organization / Institution:
Not specified
Author:
Joshua T. Smith, Mary Sage, Herb Szeto, Yun Lu, Adriana Martinez, Patricia Kipnis, Vincent X. Liu
Target audience:
Healthcare professionals, medical researchers
Period of validity:
2018-2019
Approval date:
Not specified
Date of changes:
Not specified
Note:
Context
Note:
Year
Theme:
Mental health, substance use disorder
Document Type:
Quick Reference Guide
Organization:
Sunshine Mental Health and Wellbeing Centre
Target Audience:
Clinical staff, healthcare professionals
Review Date:
Every 2 years
Note:
Year
Consumptive Loss:
The water removed from an available raw water source without returning to the same source.
Water Loss:
The difference between the volume of water supplied to a system and volume of water used in the industrial process.
Date:
_____________
Year:
2022
Region / city:
Canberra
Topic:
Alcohol withdrawal treatment
Document type:
Procedure
Organization / institution:
Canberra Health Services
Author:
Unknown
Target audience:
Medical and nursing staff at Alcohol and Drug Service (ADS)
Period of validity:
Not specified
Approval date:
17 June 2022
Revision date:
Not specified
Year:
1999
Region / city:
Australia
Topic:
Health / Substance Withdrawal
Document type:
Questionnaire
Organization:
National Centre for Education and Training on Addiction (NCETA)
Author:
Srisurapanont, M., Jarusuraisin, N., Jittiwutikan, J., Fischer, J.A., Roche, A.M., Duraisingam, V.
Target audience:
Healthcare professionals, researchers
Effective period:
N/A
Approval date:
N/A
Date of changes:
N/A
Year:
2025
Region / City:
Wisconsin
Theme:
Public health, disability services
Document type:
Form, Request
Agency:
Department of Health Services, Division of Public Health
Author:
Not specified
Target audience:
IRIS participants, legal guardians, representatives
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Year:
2024
Region / city:
Australia
Topic:
Renewable energy, certification, and regulatory compliance
Document type:
Form
Agency:
Clean Energy Regulator
Target audience:
Registered profile holders in the PGO system
Effective date:
2024
Date of approval:
03/11/2025
Withdrawal option:
Yes
Signature required:
Yes
Contact information:
[email protected]
Method of submission:
Email
Form completion method:
Electronic or hand-written
Context:
This document is a form to notify authorisations, transfers, or withdrawals related to the Product Guarantee of Origin (PGO) certificates, in accordance with the Future Made in Australia (Guarantee of Origin) Act 2024.
Year:
Not provided
Region / City:
Not provided
Subject:
Medical Research, Participant Consent
Document Type:
Study Form
Organ / Institution:
Not provided
Author:
Not provided
Target Audience:
Study team, Research Participants
Period of Validity:
Not provided
Approval Date:
Not provided
Amendment Date:
Not provided
Note:
Year
Organization / Institution:
University of Surrey
Target Audience:
Students
Year:
2021
Region / city:
South Africa
Topic:
Retirement Savings Withdrawal
Document type:
Form
Organization:
Fairsure Administration
Author:
Fairsure Administration
Target audience:
Fund members
Effective period:
From 1 March 2021
Approval date:
Not specified
Modification date:
Not specified
Year:
not specified
Country:
United Kingdom
Medication:
Zopiclone
Therapeutic class:
Hypnotic
Indication:
Insomnia
Licensed use duration:
Up to 4 weeks
Adult licensed dose:
7.5 mg at bedtime
Elderly licensed dose:
3.75–7.5 mg at bedtime
Off-licence use:
Yes
Primary topic:
Dose reduction and withdrawal
Withdrawal risks:
Physical and psychological withdrawal symptoms
Target population:
Adult patients using zopiclone long term
Recommended tapering pace:
No faster than one change per week
Dose forms:
3.75 mg tablets, 7.5 mg tablets
Reference bodies:
All Wales Medicines Strategy Group; NICE
Document components:
Clinical guidance; tapering schedule; patient reduction record